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1. Introduction 
Polymorphonuclear leukocytes promote superox- 
ide anion (0;) production when stimulated with ap- 
propriate stimuli [l-6]. The enhanced 0; produc- 
tion requires intact, viable cells and proceeds indepen- 
dently of phagocytosis [6-81. Furthermore, the reac- 
tion was found to be inhibited with various potent 
inhibitors of serine proteases uch as d&isopropyl flu- 
orophosphate (Dip-F) [9-l 21. Although there is no 
direct evidence, the availabe information suggests that 
a certain chymotrypsin-like serine protease is involved 
in the activation of an O;-forming enzyme, probably 
a NAD(P)H oxidase which is embedded in the surface 
membrane of leukocytes [3,13-191. 
To clarify the inhibitory mechanism of Dip-F, we 
studied the effect of the inhibitor on activation of the 
O;-forming enzyme by measuring its activity in a par- 
ticulate fraction isolated from sonicated guinea pig 
polymorphonuclear leukocytes [ 18,191. The O;- form- 
ing activity of the leukocytes stimulated with com- 
plement-treated zymosan (C3b-zymosan) in the pres- 
ence of Dip-F was found to be markedly lower than 
that stimulated in the absence of Dip-F, though the 
inhibitor did not influence the isolated enzyme at all. 
These results, indicating that Dip-F inhibits strondy 
the activation process of a certain O;-forming enzyme, 
probably a NAD(P)H oxidase, with C3b-zymosan, are 
reported here. 
2. Materials and methods 
2.1. C3bzymosan 
A suspension of zytiosan (30 mg in 10 ml saline) 
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was treated by heating for 10 min at 90°C and washed 
3 times with 20 mM phosphate-buffered saline (PH 7.4). 
The zymosan was then reacted with 6.0 ml freshly 
isolated guinea pig serum for 30 min at 37°C [7]. 
After washing with Krebs-Ringer phosphate buffer 
supplemented with 5.6 mM D-glucose (pH 7.4) (buffer 
1), the C3b-bound zymosan thus formed was suspend- 
ed in buffer 1 and used as a stimulus. 
2.2. Measurement of 0; production by intact leuko- 
cy tees 
Guinea pig polymorphonuclear leukocytes were 
isolated from the peritoneal cavity of animals intra- 
peritoneally injected with casein [ 121. The determina- 
tion of 0; production was performed by measuring 
the superoxide dismutase-inhibitable reduction of 
equine ferricytochrome c by 0; [ 121. For this purpose, 
leukocytes (6 X lo6 cells) were incubated in the pres- 
ence or absence of 0.9 mg C3b-zymosan in 1 .O ml 
buffer 1 supplemented with 0.25% bovine serum 
albumin and 100 nmol cytochrome c for 15 min at 
37°C [12]. After incubation, the reaction mixtures 
were centrifuged at 4”C, and the absorption spectra 
of supernatants were measured from 540-560 nm. 
The abounts of reduced cytochrome c were calculated, 
using an absorption coefficient of 21 .l mM_’ cm-’ 
at 550 nm (reduced-oxidized) [20]. 
2.3. Solubilization of the O;-forming enzyme 
The O;-forming enzyme of leukocytes was isolated 
as in [ 18,191 for isolation of NAD(P)H oxidase from 
human neutrophils. The C3b-zymosan-treated or non- 
treated leukocytes (1.5 X lOa cells) were washed 2 
times with buffer 1 and resuspended in 8.0 ml cold 
0.34 M sucrose in 0.15 M NaCl (PH 7.5). The cells 
were then disrupted by sonication at 0°C (two 20 s 
pulses at 160 W interrupted by a 30 s cooling period) 
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using a Heat System W220F instrument fitted with a 
cuphorn. After removal of zymosan together with cell 
debris and nuclei by centrifugation at 400 X g for 10 
min, the particulate fraction from the disrupted cells 
was sedimented by centrifugation at 100 000 X g for 
30 min. The particles sedimented were washed 2 times 
with 0.35 M sucrose in 0.15 M NaCl and suspended in 
the same medium. 
Solubilization of the O;-forming enzyme from the 
particles was performed using 20 mM glycine buffer 
supplemented with 0.4% Triton X-100, 2 mM NaN, 
and 1.6 pm CaClz (pH 8.4) (buffer 2). The particle 
suspension (5.0 ml) was mixed with 5.0 ml buffer 2 
and sonicated at 0°C (three 15 s pulses at 75 W with 
a 45 s cooling period between pulses), using the above 
instrument, fitted with a microtip. The sonicated 
mixture thus obtained was used as a source of the O;- 
forming enzyme asin [18,19]. 
The O;-forming enzyme activity of the solubilized 
fraction was assayed at 22°C by measuring a differ- 
ence spectrum which developed between a pair of re- 
action mixtures containing the enzyme together with 
cytochrome c incubated under identical conditions, 
except that one contained 30 pg superoxide dismutase 
and the other did not. The reaction mixture used con- 
tained the enzyme, 80 nmol ferricytochrome c, 0.1 mM 
NADPH, 0.1 mM FAD and 0.1 mM NaNa in 1 .O ml 
12.5 mM potassium phosphate buffer (PH 7.4). The 
amount of 0; formed was calculated from the dif- 
ference spectrum at 550 nm measured by the use of a 
Hitachi double beam recording spectrophotometer, 
model 200-20, as described for the measurement of 
0; production by intact leukocytes. 
2.4. Materials 
Protein concentration of solubilized O;-forming 
enzyme preparations was determined by the protein 
assay reagent (Bio Rad Labs), using bovine IgG as a 
standard protein. Zymosan, equine ferricytochrome 
c, FAD, NADPH, NADH and bovine superoxide dis- 
mutase were purchased from Sigma Chemical Co. 
3. Results 
As observed with human leukocytes [7], guinea pig 
peritoneal polymorphonuclear leukocytes also pro- 
moted 0; production estimated by superoxide dis- 
mutase-inhibitable cytochrome c reduction, when 
exposed to C3b-zymosan (table 1). The enhancement 
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Table 1 
Inhibition of 0; production (nmol/6 X 10’ cells) from 
leukocytes wtth Dip-F 
Dip-F Stimulated Non-stimulated 
(mM) cells cells 
0 56.2 0.2 
2 21.6 0.3 
10 0.1 0.4 
The leukocytes were incubated with varying concentrattons 
of Dip-F for 15 min at 37°C and then stimulated or not stim- 
ulated with C3b-zymosan. The amounts of 0; produced 
from the stimulated or non-stimulated cells were determined 
by measuring the superoxide dismutase-mhibitable cyto- 
chrome c reduction at 37°C for IS min. The cytochrome c 
reduction in each reaction mixture containing 30 pg super- 
oxide dismutase also was measured as control 
of 0; production was found to be markedly inhibited 
with Dip-F, as in the case of stimulation with antigen- 
antibody complexes or concanavalin A [ 121; incuba- 
tion of leukocytes with 10 mM Dip-F caused com- 
plete inhibition of 0; production. Both Dip-F and 
2-propanol used as a solvent of the inhibitor at each 
concentration added did not significantly influence 
the cell viability, as estimated by a trypan blue exclu- 
sion test [ 12,2 11. Hence the effect of Dip-F on 0; 
production may be caused by direct inhibition of the 
activation process of a certain O;-forming enzyme 
with C3b-zymosan. 
To study this point further, the effect of Dip-F on 
the O;-forming enzyme was determined by measuring 
the enzyme activity. For this purpose, the enzyme 
was solubilized with Triton X-100 from a particulate 
fraction of sonicated leukocytes and its activity was 
assayed by measuring superoxide dismutase-inhibitable 
cytochrome c reduction, as in [18,19]. When the sol- 
ubilized fraction was prepared from the leukocytes 
stimulated with C3b-zymosan for 15 min at 37”C, 
superoxide dismutase-inhibitable cytochrome c reduc- 
tion attributable to 0; formation was found to pro- 
ceed. 
To confirm that the measured rate of 0; forma- 
tion was an accurate reflection of the amount of the 
O;-forming enzyme embedded in the particles, we 
therefore conducted a series of experiments. Table 2 
shows the effect of omission ofindividual components 
of the reaction mixture. The 0; formation observed 
was dependent on the presence of both NADPH and 
a heat-labile factor, probably NAD(P)H oxidase, in 
the solubilized fraction. The O;-forming rate increased 
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Table 2 Table 3 
Requirement for 0;dependent cytochrome c reduction by 
solubilized preparations 
Inhibitory effect of Dip-F on activation of the O;-forming 
enzyme with C3~zymosan 
Conditions 0; production 
(nmof . 5 min-’ . mg 
protein-‘) 
Preparations from 
leukocytes 
Stimulated in the 
0; production 
@mol. 5 min-’ . mg protein-‘) 
Complete reaction mixture 
-FAD 
-NADPH 
-NADPH, + 0.1 mM NADH 
-Cytochrome c 
Heated fraction 
12.3 
5.4 
2.2 
9.0 
0.0 
0.0 
abcence of Dip-F 
Stimulated in the 
20.4 
presence of Dip-F 
Non-stimulated in the 
4.5 
absence of Dip-F 
Non-stimulated in the 
7.0 
presence of Dip-F 7.6 
The reactions were performed as in section 2, using the solu- 
bilized fraction from the leukocytes stimulated with C!3b- 
zymosan for 15 min at 37°C. Heated fraction was prepared 
by heating for 30 min at 7O’C 
on the addition of FAD, as in the case of NAD(P)H 
oxidase of human neutrophils [18,191. The 0; for- 
mation was also observed when NADPH was replaced 
by NADH, but NADH was less effective as electron 
donor than NADPH. The O;-forming rate did not 
decline during the 15 min incubation period and was 
proportional to protein concentration, when deter- 
mined under the optimum condition thus established. 
The solubilized fractions containing the O;-forming enzyme 
were prepared from the leukocytes stimulated or not stimu- 
lated with C3b-zymosan in either the presence or absence of 
10 mM Dip-F, and the 0;dependent cytochrome c reducing 
activity was measured as in section 2 
cells. The O;-forming enzyme, probably NAD(P)H 
oxidase, of guinea pig polymorphonuclear leukocytes 
was found to be similarly solubilized and also to be 
activated by stimulation with C3b-zymosan. 
On the basis of the above results, we attempted to 
study the effects of stimulation of leukocytes with 
C3b-zymosan and of the presence of Dip-F during the 
stimulation on the O;-forming enzyme activity. Table 
3 shows that the stimulation with C3b-zymosan i - 
creased the enzyme activity in the solubilized fraction. 
Furthermore, the presence of 10 mM Dip-F was found 
to abolish the increase in the activity by stimulation 
with C3b-zymosan. On the contrary, 10 mM Dip-F 
did not influence the activity of solubilized enzyme 
at all. These results demonstrate hat the inhibitory’ 
effect of Dip-F on the enhancement of 0; produc- 
tion with C3b-zymosan iscaused by direct i~ibition 
of the activation process of the O;-forming enzyme 
initiated by the stimulus. 
In 19-l l] the 0; production stimulated from 
human leukocytes was inhibited by substrates of
chymotryps~. Dip-F ~ibited the 0; production 
from guinea pig polymorphonuclear leukocytes 
stimulated with antigen-antibody complexes and 
concanavalin A [ 121 though the inhibitor did not in- 
fluence the binding reactions of these stimuli to the 
cell surface of leukocytes. These results uggest the 
involvement of a certain serine protease in the trig- 
gering mechanism of various timuli, including C3b- 
zymosan, leading to the activation of an O;-forming 
enzyme, probably NAD(P)H oxidase. In fact, the 
measurements of the O;-forming enzyme activity here 
demonstrate hat a certain up-F-sensitive protease is 
essential for the activation process of N~~~~ oxi- 
dase. 
4. Discussion 
In [ 18,191 the NAD(P)H oxidase of human neutro- 
phils responsible for 0; formation was reported solu- 
bilized by Triton X-100 treatment of a particulate 
O;-forming system obtained from C3b-zymosan-acti- 
vated cells, though only little O;-forming activity was 
detected in the solub~ized fraction from non-activated 
(1) 
(2) 
The serine protease may play the role of: 
The NAD(P)H oxidase may exist as a precursor 
and be altered to an active enzyme by limited 
proteolysis by the serine protease, when leuko- 
cytes are stimulated with appropriate stimuli; 
The NAD(P)H oxidase may be incorporated into 
the cell membrane by perturbation of the molec- 
ular organization of the membrane which may be 
caused by appropriate stimuli, and this process 
may be mediated by the serine protease. 
To solve which role may be operative, further purifica- 
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tion and identification of the NAD(P)H oxidase as 
well as demonstration of existence of its precursor 
should be attempted. In addition, studies on localiza- 
tion of the serine protease in leukocyte cells and also 
its activity whereby the NAD(P)H oxidase may be 
made activated or operative will be required for eluci- 
dation of the mechanism of leukocytes to enhance 
0; production when exposed to various stimuli. 
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